Richard CROWLEY insider trades: Savient Pharmaceuticals (SVNT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 15, 2013 | SVNT | ↓ Sell | 113,740 | $0.08 | $9K | Direct | Oct 17, 2013 (2d) |
| Apr 30, 2013 | SVNT | ↓ Sell10b5-1 | 2,485 | $0.74 | $2K | Direct | May 1, 2013 (1d) |
| Feb 4, 2013 | SVNT | ↓ Sell10b5-1 | 48,900 | $1.03 | $51K | Direct | Feb 6, 2013 (2d) |
| Jan 31, 2013 | SVNT | ↓ Sell10b5-1 | 2,415 | $1.02 | $2K | Direct | Feb 4, 2013 (4d) |
| Oct 31, 2012 | SVNT | ↓ Sell10b5-1 | 2,010 | $1.45 | $3K | Direct | Nov 6, 2012 (6d) |
| Aug 2, 2012 | SVNT | ↓ Sell10b5-1 | 2,500 | $0.62 | $2K | Direct | Aug 3, 2012 (1d) |
| May 1, 2012 | SVNT | ↓ Sell10b5-1 | 9,200 | $2.35 | $22K | Direct | May 1, 2012 (0d) |
| Nov 21, 2011 | SVNT | ↑ Buy | 3,000 | $2.53 | $8K | Direct | Nov 22, 2011 (1d) |
| Nov 3, 2008 | IMCL | ↓ Sell | 11,957 | $68.72 | $822K | Direct | Nov 7, 2008 (4d) |
| Sep 2, 2008 | IMCL | ↓ Sell | 11,957 | $64.40 | $770K | Direct | Sep 4, 2008 (2d) |
| Jul 31, 2008 | IMCL | ↓ Sell | 26,957 | $64.16 | $1.7M | Direct | Aug 1, 2008 (1d) |
| Nov 19, 2007 | IMCL | ↓ Sell | 9,150 | $42.65 | $390K | Direct | Nov 21, 2007 (2d) |
| Jul 3, 2006 | IMCL | ↓ Sell | 1,000 | $38.68 | $39K | Direct | Jul 5, 2006 (2d) |
| Jun 1, 2006 | IMCL | ↓ Sell | 1,000 | $39.84 | $40K | Direct | Jun 5, 2006 (4d) |
| May 1, 2006 | IMCL | ↓ Sell | 1,000 | $35.96 | $36K | Direct | May 3, 2006 (2d) |
| Apr 21, 2006 | IMCL | ↓ Sell | 1,000 | $35.00 | $35K | Direct | Apr 24, 2006 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Richard CROWLEY's insider trades
Richard CROWLEY is Co-President and COO at Savient Pharmaceuticals (SVNT). Since Apr 21, 2006, Richard has reported 1 open-market purchase worth $8K and 15 sales worth $4.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
6 sales (2% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (9 filings), grants and awards (6 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SVNT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.